中华病理学杂志Pub Date : 2025-03-08DOI: 10.3760/cma.j.cn112151-20240923-00628
W T Huang, W Zhang, J P Yuan, X X Yu, H H He
{"title":"[Primary perivascular epithelioid tumor of the larynx: a clinicopathological analysis of 2 cases].","authors":"W T Huang, W Zhang, J P Yuan, X X Yu, H H He","doi":"10.3760/cma.j.cn112151-20240923-00628","DOIUrl":"10.3760/cma.j.cn112151-20240923-00628","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 3","pages":"275-277"},"PeriodicalIF":0.0,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华病理学杂志Pub Date : 2025-03-08DOI: 10.3760/cma.j.cn112151-20241013-00675
Z Q Zhao, J Xu, S H Dong, A D Liu, Y Yang, H P Yin, G Y Xiong
{"title":"[YAP1::KMT2A fusion sclerosing epithelioid fibrosarcoma: report of a case].","authors":"Z Q Zhao, J Xu, S H Dong, A D Liu, Y Yang, H P Yin, G Y Xiong","doi":"10.3760/cma.j.cn112151-20241013-00675","DOIUrl":"10.3760/cma.j.cn112151-20241013-00675","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 3","pages":"284-286"},"PeriodicalIF":0.0,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华病理学杂志Pub Date : 2025-03-08DOI: 10.3760/cma.j.cn112151-20240926-00640
Q Da, S H Wang, W W Wang, C X Yang, B Wang, M Ruan, Z M Fu, Y Y Xu, Y B Zhou, C F Wang, D R Zhong, D G Liu
{"title":"[Progress and challenges of pathological artificial intelligence in the era of large models].","authors":"Q Da, S H Wang, W W Wang, C X Yang, B Wang, M Ruan, Z M Fu, Y Y Xu, Y B Zhou, C F Wang, D R Zhong, D G Liu","doi":"10.3760/cma.j.cn112151-20240926-00640","DOIUrl":"10.3760/cma.j.cn112151-20240926-00640","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 3","pages":"305-309"},"PeriodicalIF":0.0,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华病理学杂志Pub Date : 2025-03-08DOI: 10.3760/cma.j.cn112151-20241125-00784
Y X Li, S Xing, X S Yan, B Wang, Z H Liu, X Wang, W W Fu
{"title":"[High-grade B-cell lymphoma with 11q aberrations originating from bilateral ovaries: report of a case].","authors":"Y X Li, S Xing, X S Yan, B Wang, Z H Liu, X Wang, W W Fu","doi":"10.3760/cma.j.cn112151-20241125-00784","DOIUrl":"10.3760/cma.j.cn112151-20241125-00784","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 3","pages":"290-293"},"PeriodicalIF":0.0,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华病理学杂志Pub Date : 2025-03-08DOI: 10.3760/cma.j.cn112151-20241225-00871
Y F Wang, X Zong, W C Xue
{"title":"[Insight into the grading of breast phyllodes tumors].","authors":"Y F Wang, X Zong, W C Xue","doi":"10.3760/cma.j.cn112151-20241225-00871","DOIUrl":"10.3760/cma.j.cn112151-20241225-00871","url":null,"abstract":"<p><p>Phyllodes tumors (PT) of the breast is a rare fibroepithelial tumor, which can be divided into benign, borderline and malignant pathological types according to its histological characteristics. Malignant phyllodes tumor (MPT) accounts for 10%-20% of PT and has the ability of local recurrence and distant metastasis. Therefore, accurate diagnosis and identification of MPT are particularly important for patients to obtain appropriate treatment at the initial diagnosis. At present, histological morphology is the only diagnostic basis for MPT. However, due to the fact that phyllode tumor itself is a continuous disease spectrum with overlapping histological features, and the diagnostic classification adopts many histological parameters and their evaluation is subjective, pathologists lack consistency in MPT grading, and the biological behavior of PT is not completely consistent. Therefore, the existing MPT classification standards are facing challenges, and the accurate and reproducible classification is worthy of further exploration.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 3","pages":"219-223"},"PeriodicalIF":0.0,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华病理学杂志Pub Date : 2025-03-08DOI: 10.3760/cma.j.cn112151-20240927-00645
L Xu, B Luo, L Xu, H L Yan, J P Yuan, X Y Zhang
{"title":"[Clinicopathological analysis of 2 cases of primary dedifferentiated liposarcoma of the heart].","authors":"L Xu, B Luo, L Xu, H L Yan, J P Yuan, X Y Zhang","doi":"10.3760/cma.j.cn112151-20240927-00645","DOIUrl":"10.3760/cma.j.cn112151-20240927-00645","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 3","pages":"281-283"},"PeriodicalIF":0.0,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华病理学杂志Pub Date : 2025-03-08DOI: 10.3760/cma.j.cn112151-20241017-00685
L Dong, Y J Gu, Z Y Wang, H F Wang, J L Xie
{"title":"[Desmoid fibromatosis with CTNNB1 exon 3 deletion-inversion complex mutation: report of a case].","authors":"L Dong, Y J Gu, Z Y Wang, H F Wang, J L Xie","doi":"10.3760/cma.j.cn112151-20241017-00685","DOIUrl":"10.3760/cma.j.cn112151-20241017-00685","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 3","pages":"287-289"},"PeriodicalIF":0.0,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华病理学杂志Pub Date : 2025-03-08DOI: 10.3760/cma.j.cn112151-20240819-00555
X Q Li, Y L Wang, Z Zhang, J S Zhao, W M Kong, X Z Pan, L R Bao, K Z Yang, H Y Gu, J G Wang
{"title":"[Clinicopathological significance of DICER1 mutation in follicular thyroid carcinoma].","authors":"X Q Li, Y L Wang, Z Zhang, J S Zhao, W M Kong, X Z Pan, L R Bao, K Z Yang, H Y Gu, J G Wang","doi":"10.3760/cma.j.cn112151-20240819-00555","DOIUrl":"10.3760/cma.j.cn112151-20240819-00555","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the clinical and pathological significance of the DICER1 mutation in follicular thyroid carcinoma (FTC). <b>Methods:</b> Sixty-eight cases of primary FTC resected between 2009 and 2023 were retrieved from The Affiliated Hospital of Qingdao University, Qingdao, China. Sanger sequencing was performed to identify DICER1 and TERT promoter mutations in all cases. Cases with DICER1 or TERT promoter mutations were subject to additional examination of potential mutations in KRAS, HRAS, and NRAS. The clinical and pathological features of DICER1-mutant FTCs were then analyzed. The relationship between DICER1 mutations and TERT-promoter/RAS mutations was also assessed. <b>Results:</b> DICER1 mutations were detected in 16 of the 68 FTC cases (23.5%), with 11 near E1813 at exon 25, 6 near D1709 at exon 24, and 1 in the splice region of exon 25. Two cases harbored two (distinct) mutations. All patients with DICER1-mutant FTC were female. Compared with patients with DICER1-wild-type FTC, those with DICER1-mutant were much younger, and had a higher proportion of minimally invasive subtype. Nine FTCs with DICER1 mutations were subject to further sequencing on adjacent non-cancerous tissues or lymph node tissues, but no mutations were detected. TERT-promoter or RAS hotspot mutations were not identified in any of the DICER1-mutant cases. However, TERT-promoter mutation was found in 6 DICER1-wild-type cases (8.8%, 6/68), with 3 cases also having RAS hotspot mutations and exhibiting highly aggressive biological behaviors. <b>Conclusion:</b> DICER1 mutations may occur in FTCs and appear mutually exclusive with RAS and TERT-promoter mutations, warranting further study as RAS-like mutations.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 3","pages":"250-258"},"PeriodicalIF":0.0,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华病理学杂志Pub Date : 2025-03-08DOI: 10.3760/cma.j.cn112151-20240816-00525
A Q Li, X Shen, X C Fei, M Ruan, L Dong, C F Wang
{"title":"[Clinicopathological features of hereditary breast cancer and advances in germline testing].","authors":"A Q Li, X Shen, X C Fei, M Ruan, L Dong, C F Wang","doi":"10.3760/cma.j.cn112151-20240816-00525","DOIUrl":"10.3760/cma.j.cn112151-20240816-00525","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 3","pages":"294-297"},"PeriodicalIF":0.0,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华病理学杂志Pub Date : 2025-03-08DOI: 10.3760/cma.j.cn112151-20240817-00543
J N Zhao, H R Zhang, Y P Liu
{"title":"[Characteristic PIK3CA gene mutation in breast cancer].","authors":"J N Zhao, H R Zhang, Y P Liu","doi":"10.3760/cma.j.cn112151-20240817-00543","DOIUrl":"10.3760/cma.j.cn112151-20240817-00543","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the mutation spectrum of the PIK3CA gene in breast cancer, providing a new basis for the precise treatment of breast cancer with PIK3CA inhibitors. <b>Methods:</b> A retrospective analysis was conducted on 144 breast cancer patients who underwent biopsy before neoadjuvant therapy archived from 2015 to 2020 at the Fourth Hospital of Hebei Medical University. Next-generation sequencing (NGS) was utilized to detect the mutations of 520 genes closely related to the development of solid tumors and targeted therapies. The study compared the differences between reported mutation types and focused on analyzing the mutation status of the PIK3CA gene. The clinical and pathological characteristics, including age of onset, molecular subtypes, and Ki-67, were also analyzed. The correlation between PIK3CA mutations and clinicopathological characteristics was examined using Pearson×s chi-square test and Mann Whitney test. Logistic regression was employed to analyze factors influencing PIK3CA mutations. Kaplan-Meier survival analysis and Cox regression models were constructed using R programming. <b>Results:</b> Among the 144 breast cancer samples, 61 (42.3%, 61/144) exhibited PIK3CA gene mutations, of which 23 cases (53.5%, 23/43) were HER2-positive breast cancer, 28 cases (44.4%, 28/63) were luminal breast cancer, and 10 cases (27.8%, 10/36) were triple-negative breast cancer. Of the detected mutations, three hotspot mutations (H1047R, E545K, and E542K) accounted for 72.1% of the total PIK3CA mutations, with H1047R (52.4%), E545K (16.4%), and E542K (3.3%) most commonly detected. The remaining rare mutations accounted for 26.3%. Co-mutations involving PIK3CA and other genes were also observed in the cohort, occurring with TOP2A and FOXA1, while being mutually exclusive with GATA3 and BRCA2. PIK3CA mutations were significantly associated with HER2 status and were not significantly correlated with the patient's age, menopausal status, HR status, Ki-67 index, molecular typing, TNM stage or pCR status. Likewise, no significant correlation was found between different PIK3CA mutation status and overall survival. <b>Conclusions:</b> This cohort study shows the overall mutation rate of PIK3CA in breast cancer and the mutation frequencies across different molecular subtypes. The findings reveal a significant correlation between PIK3CA mutations and HER2 status, which provides a new basis for the precise treatment of breast cancer with PIK3CA inhibitors.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 3","pages":"243-249"},"PeriodicalIF":0.0,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}